I medici

PD Dr. med.
Marcello Di Valentino

Formazione

Laurea in medicina
2001
Università Politecnica delle Marche (IT)

Specializzazione

Cardiologia
2008

Ruolo

Medico consulente
Specialista in cardiologia

Affiliazioni

Società Svizzera di Cardiologia (SSC)
Società Europea di Cardiologia (ESC)
Associazione Europea per la Prevenzione Cardiovascolare e per la Riabilitazione (EACPR)

Anno di nascita

1972

Inizio attività in clinica

2023

Contatto

Ambulatorio di cardiologia
Clinica Moncucco
T+ 41 91 960 86 23
cardiologia@moncucco.ch

Contatto studio privato

Centromedico Bellinzona
Viale Officina 7, 6500 Bellinzona
T+ 41 91 640 24 24

Lingue

Italiano
Tedesco
Inglese

Esperienze professionali

Caposervizio cardiologo, servizio di cardiologia, Ospedale Regionale di Bellinzona e Valli (ad oggi)
2017
Collaboratore a tempo parziale c/o Centro medico di Bellinzona (ad oggi)
2017
Capoclinica cardiologo, servizio di cardiologia, Ospedale Regionale di Bellinzona e Valli
2011 / 2017
Medico ospedaliero facente funzione di capoclinica per il servizio di cardiologia, Ospedale Regionale di Bellinzona e Valli
2010 / 2010

Altre attività

Nomina di libero docente (PD) presso la Facoltà di scienze biomediche dell’Università della Svizzera italiana, 2018

Pubblicazioni

Long-term risk of adverse outcomes according to atrial fibrillation type. Blum S, Aeschbacher S, Coslovsky M, Meyre PB, Reddiess P, Ammann P, Erne P, Moschovitis G, Di Valentino M, Shah D, Schläpfer J, Müller R, Beer JH, Kobza R, Bonati LH, Moutzouri E, Rodondi N, Meyer-Zürn C, Kühne M, Sticherling C, Osswald S, Conen D; BEAT-AF and Swiss-AF investigators. Sci Rep. 2022 Feb 9;12(1):2208
Silent brain infarcts impact on cognitive function in atrial fibrillation. Kühne M, Krisai P, Coslovsky M, Rodondi N, Müller A, Beer JH, Ammann P, Auricchio A, Moschovitis G, Hayoz D, Kobza R, Shah D, Stephan FP, Schläpfer J, Di Valentino M, Aeschbacher S, Ehret G, Eken C, Monsch A, Roten L, Schwenkglenks M, Springer A, Sticherling C, Reichlin T, Zuern CS, Meyre PB, Blum S, Sinnecker T, Würfel J, Bonati LH, Conen D, Osswald S; Swiss-AF Investigators. Eur Heart J. 2022 Jun 6;43(22):2127-2135.
Role of genetic testing in young patients with idiopathic atrioventricular conduction disease. Auricchio A, Demarchi A, Özkartal T, Campanale D, Caputo ML, Di Valentino M, Menafoglio A, Regoli F, Facchini M, Del Bufalo A, Foglia P, Ferrari N, Bomio F, Medeiros-Domingo A, Moccetti T, Pedrazzini GB, Klersy C, Conte G. Europace. 2023 Feb 16;25(2):643-650.
Physical activity and brain health in patients with atrial fibrillation. Herber E, Aeschbacher S, Coslovsky M, Schwendinger F, Hennings E, Gasser A, Di Valentino M, Rigamonti E, Reichlin T, Rodondi N, Netzer S, Beer JH, Stauber A, Müller A, Ammann P, Sinnecker T, Duering M, Wuerfel J, Conen D, Kühne M, Osswald S, Bonati LH; SWISS-AF Investigators. Eur J Neurol. 2023 Mar;30(3):567-577.
Management of hemodynamically stable wide QRS complex tachycardia in patients with implantable cardioverter defibrillators. Regoli FD, Cattaneo M, Kola F, Thartori A, Bytyci H, Saccarello L, Amoruso M, Di Valentino M, Menafoglio A. Front Cardiovasc Med. 2023 Jan 4;9:1011619.
Heart rate and adverse outcomes in patients with prevalent atrial fibrillation. Moschovitis G, Johnson LSB, Blum S, Aeschbacher S, De Perna ML, Pagnamenta A, Mayer Melchiorre PA, Benz AP, Kobza R, Di Valentino M, Zuern CS, Auricchio A, Conte G, Rodondi N, Blum MR, Beer JH, Kühne M, Osswald S, Conen D; BEAT-AF and Swiss-AF investigators. Open Heart. 2021 Apr;8(1):e001606. doi: 10.1136/openhrt-2021-001606.
Biomarkers of Inflammation and Risk of Hospitalization for Heart Failure in Patients With Atrial Fibrillation. Benz AP, Aeschbacher S, Krisai P, Moschovitis G, Blum S, Meyre P, Blum MR, Rodondi N, Di Valentino M, Kobza R, De Perna ML, Bonati LH, Beer JH, Kühne M, Osswald S, Conen D; BEAT‐AF, Swiss‐AF Investigators. J Am Heart Assoc. 2021 Apr 20;10(8):e019168. doi: 10.1161/JAHA.120.019168. Epub 2021 Apr 10. (I.F. 4.863; Max R 0.794).
Alcohol consumption and risk of cardiovascular outcomes and bleeding in patients with established atrial fibrillation. Reddiess P, Aeschbacher S, Meyre P, Coslovsky M, Kühne M, Rodondi N, Baretella O, Beer JH, Kobza R, Moschovitis G, Di Valentino M, Müller C, Steiner F, Bonati LH, Sticherling C, Osswald S, Conen D; BEAT-AF and Swiss-AF investigators. CMAJ. 2021 Jan 25;193(4):E117-E123. doi: 10.1503/cmaj.200778 (I.F. 6.784; Max R 0.935).
Association of the CHA2D(S2)-VASc Score and Its Components With Overt and Silent Ischemic Brain Lesions in Patients With Atrial Fibrillation. Steiner F, Meyre PB, Aeschbacher S, Coslovsky M, Sinnecker T, Blum MR, Rodondi N, Cereda CW, Di Valentino M, Wenger F, Cussigh A, Krisai P, Roten L, Reichlin T, Conen D, Osswald S, Bonati LH, Kühne M; Swiss-AF Investigators. Front Neurol. 2021 Jan 12;11:609234. doi: 10.3389/fneur.2020.609234. eCollection 2020. (I.F. 3.552; Max R 0.746).
Association of psychosocial factors with all-cause hospitalizations in patients with atrial fibrillation. Meyre PB, Springer A, Aeschbacher S, Blum S, Rodondi N, Beer JH, Di Valentino M, Ammann P, Blum M, Mathys R, Meyer-Zürn C, Bonati LH, Sticherling C, Schwenkglenks M, Kühne M, Conen D, Osswald S; Swiss-AF investigators. Clin Cardiol. 2021 Jan;44(1):51-57. doi: 10.1002/clc.23503. Epub 2020 Nov 10.
Heart Rate Variability Triangular Index as a Predictor of Cardiovascular Mortality in Patients With Atrial Fibrillation. Hämmerle P, Eick C, Blum S, Schlageter V, Bauer A, Rizas KD, Eken C, Coslovsky M, Aeschbacher S, Krisai P, Meyre P, Vesin JM, Rodondi N, Moutzouri E, Beer J, Moschovitis G, Kobza R, Di Valentino M, Corino VDA, Laureanti R, Mainardi L, Bonati LH, Sticherling C, Conen D, Osswald S, Kühne M, Zuern CS; Swiss‐AF Study Investigators. J Am Heart Assoc. 2020 Aug 4;9(15):e016075. doi: 10.1161/JAHA.120.016075. Epub 2020 Jul 28. (I.F. 4.863; Max R 0.794).
Dipyridamole stress echocardiography in brain death: the need for a comprehensive approach in heart donors' evaluation. Scicchitano P, Di Valentino M. Minerva Cardioangiol. 2020 Jun;68(3):246-248. doi: 10.23736/S0026-4725.20.05270-6. (I.F. 0.695; Max R 0.056).
Blum S, Aeschbacher S, Meyre P, Zwimpfer L, Reichlin T, Beer JH, Ammann P, Auricchio A, Kobza R, Erne P, Moschovitis G, Di Valentino M, Shah D, Schläpfer J, Henz S, Meyer-Zürn C, Roten L, Schwenkglenks M, Sticherling C, Kühne M, Osswald S, Conen D; Swiss‐AF Investigators. Incidence and Predictors of Atrial Fibrillation Progression. J Am Heart Assoc. 2019 Oct 15;8(20):e012554. doi: 10.1161/JAHA.119.012554. Epub 2019 Oct 8 (I.F. 4.863; Max R 0.794).
Conen D, Rodondi N, Müller A, Beer JH, Ammann P, Moschovitis G, Auricchio A, Hayoz D, Kobza R, Shah D, Novak J, Schläpfer J, Di Valentino M, Aeschbacher S, Blum S, Meyre P, Sticherling C, Bonati LH, Ehret G, Moutzouri E, Fischer U, Monsch AU, Stippich C, Wuerfel J, Sinnecker T, Coslovsky M, Schwenkglenks M, Kühne M, Osswald S; Swiss-AF Study Investigators. Relationships of Overt and Silent Brain Lesions With Cognitive Function in Patients With Atrial Fibrillation. J Am Coll Cardiol. 2019 Mar 12;73(9):989-999. doi: 10.1016/j.jacc.2018.12.039. (I. F. 19.896; Max. R. 1)
Prevalence and predictors of atrial fibrillation type among individuals with recent onset of atrial fibrillation. Swiss Med Wkly. 2018 Sep 23;148:w14652. doi: 10.4414/smw.2018.14652. eCollection 2018 Sep 10. (I. F. 1.65; Max. R. 0.565)
Ruperti Repilado FJ, Doerig L, Blum S, Aeschbacher S, Krisai P, Ammann P, Erne P, Moschovitis G, Di Valentino M, Shah D, Schläpfer J, Stempfel S, Kühne M, Sticherling C, Osswald S, Conen D.
Eggimann L, Blum S, Aeschbacher S, Reusser A, Ammann P, Erne P, Moschovitis G, Di Valentino M, Shah D, Schläpfer J, Mondet N, Kühne M, Sticherling C, Osswald S, Conen D. Risk factors for heart failure hospitalizations among patients with atrial fibrillation. PLoS One. 2018 Feb 2;13(2):e0191736. (I. F. 2.806; Max. R. 0.778)
Reusser A, Blum S, Aeschbacher S, Eggimann L, Ammann P, Erne P, Moschovitis G, Di Valentino M, Shah D, Schläpfer J, Manser S, Reichlin T, Kühne M, Sticherling C, Osswald S, Conen D. QTc interval, cardiovascular events and mortality in patients with atrial fibrillation. Int J Cardiol. 2018 Feb 1;252:101-105. (I. F. 6.189; Max. R. 0.881)
Porretta AP, Alerci M, Wyttenbach R, Antonucci F, Cattaneo M, Bogen M, Toderi M, Guerra A, Sartori F, Di Valentino M, Tutta P, Limoni C, Gallino A, vonSegesser LK. Long-term Outcomes of a Telementoring Program for Distant Teaching of Endovascular Aneurysm Repair. J Endovasc Ther. 2017 Dec;24(6):852-858. (I. F. 2.838; Max. R. 0.754)
Conen D, Rodondi N, Mueller A, Beer J, Auricchio A, Ammann P, Hayoz D, Kobza R, Moschovitis G, Shah D, Schlaepfer J, Novak J, Di Valentino M, Erne P, Sticherling C, Bonati L, Ehret G, Roten L, Fischer U, Monsch A, Stippich C, Wuerfel J, Schwenkglenks M, Kuehne M, Osswald S. Design of the Swiss Atrial Fibrillation Cohort Study (Swiss-AF): structural brain damage and cognitive decline among patients with atrial fibrillation. Swiss Med Wkly. 2017 Jul 11. (I. F. 1.65; Max. R. 0.565)
Blum S, Muff C, Aeschbacher S, Ammann P, Erne P, Moschovitis G, Di Valentino M, Shah D, Schläpfer J, Fischer A, Merkel T, Kühne M, Sticherling C, Osswald S, Conen D. Prospective Assessment of Sex-Related Differences in Symptom Status and Health Perception Among Patients With Atrial Fibrillation. J Am Heart Assoc. 2017 Jun 30;6(7). (I. F. 4.863; Max. R. 0.790)
Zimny M, Blum S, Ammann P, Erne P, Moschovitis G, Di Valentino M, Shah D, Schläpfer J, Vogt C, Tabord A, Kühne M, Sticherling C, Osswald S, Conen D. Uptake of non-vitamin K antagonist oral anti coagulants in patients with atrial fibrillation - a prospective cohort study. Swiss Med Wkly. 2017 Mar 21;147:w14410. (I. F. 1.65; Max. R. 0.565)
Porretta AP, Bianda N, Di Valentino M, Segatto JM, Santini P, Cattaneo M, Moccetti M, Limoni C, Wyttenbach R, Gallino A. A combined "in vivo" noninvasive evaluation of carotid plaques using ultrasonography and high-resolution magnetic resonance - new insight into plaque burden and vulnerability. Vasa. 2016 Sep 6:1-7. (I. F. 1.242; Max. R. 0.143)
Menafoglio A, Di Valentino M, Porretta AP, Foglia P, Segatto JM, Siragusa P, Pezzoli R, Maggi M,Romano GA, Moschovitis G, Gallino A. Cardiovascular evaluation of middle-aged individuals engaged in high-intensity sport activities: implications for workload, yield and economic costs. Br J Sports Med. 2015 Jun;49(11):757-61. (I. F. 6.557; Max. R. 0.975)
Di Valentino M, Muzzarelli S, Limoni C, Porretta AP, Rigoli A, Barazzoni F, Kaiser C, Pedrazzini G,Osswald S, Moccetti T, Gallino A. Reduction of ST-elevation myocardial infarction in Canton Ticino (Switzerland) after smoking bans in enclosed public places-: No Smoke Pub Study. Eur J Public Health. 2015 Apr;25(2):195-9. (I. F. 2.431; Max. R. 0.762)
Menafoglio A, Di Valentino M, Segatto JM, Siragusa P, Pezzoli R, Maggi M, Romano GA, Moschovitis G, Wilhelm M, Gallino A. Costs and yield of a 15-month preparticipation cardiovascular examination with ECG in 1070 young athletes in Switzerland: implications for routine ECG screening. Br J Sports Med. 2014 Aug;48(15):1157-61. (I. F. 6.557; Max. R. 0.975)
Gallino A, Stuber M, Crea F, Falk E, Corti R, Lekakis J, Schwitter J, Camici P, Gaemperli O, Di Valentino M, Prior J, Garcia-Garcia HM, Vlachopoulos C, Cosentino F, Windecker S, Pedrazzini G, Conti R, Mach F, De Caterina R, Libby P. In vivo" imaging of atherosclerosis. Atherosclerosis. 2012 Sep;224(1):25-36. Review. (I. F. 4.239; Max. R. 0.857)
Bianda N*, Di Valentino M*, Périat D, Segatto JM, Oberson M, Moccetti M, Sudano I, Santini P, Limoni C, Froio A, Stuber M, Corti R, Gallino A, Wyttenbach R. Progression of human carotid and femoral atherosclerosis: a prospective follow-up study by magnetic resonance vessel wall imaging. (*equal contribution) Eur Heart J. 2012 Jan;33(2):230-7. (I. F. 19.651; Max. R. 0.992)
Schaer BA, Osswald S, Di Valentino M, Soliman OII, Sticherling C et al. Close connection of improvement of left ventricular function by cardiac resynchronisation therapy (CRT) and incidence of arrhythmias in ICD patients. Eur J Heart Fail. 2010 Dec;12(12):1325-32. (I. F. 6.968; Max. R. 0.913)
Di Valentino M, Maeder MT, Jaggi S, Schumann J, Sommerfeld K, Piazzalonga S,Hoffmann A. Prognostic value of cycle exercise testing prior to and after outpatient cardiac rehabilitation. Int J Cardiol. 2008 Nov 24 (I. F. 6.189; Max. R. 0.881)
Stolz D, Rasch H, Linka A, Di Valentino M, Meyer A, Brutsche M, Tamm M. A randomised, controlled trial of bosentan in severe COPD. Eur Respir J. 2008 Sep;32(3):619-28 (I. F. 10.569; Max. R. 0.966)
Wyttenbach R, Braghetti A, Wyss M, Alerci M, Briner L, Santini P, Cozzi L, Di Valentino M, Katoh M, Marone C, Vock P, and Gallino A. Renal Artery Assessment with Nonenhanced Steady-State Free Precession versus Contrast-enhanced MR Angiography Radiology. 2007 Oct;245(1):186-95 (I. F. 7.296; Max. R. 0.99)
Wyttenbach R, Corti R, Alerci M, Cozzi L, Di Valentino M, Segatto JM, Badimon JJ, Fuster V and Gallino A. Effects of Percutaneous Transluminal Angioplasty and Endovascular Brachytherapy on Vascular Remodeling of Human Femoropopliteal Artery: 2 Years Follow-up by Noninvasive Magnetic-Resonance-Imaging. Eur J Vasc Endovasc Surg. 2007 Aug 2 (I. F. 4.061; Max. R. 0.928)
Di Valentino M, Alerci M, Bogen M, Tutta P, Sartori F, Marty B, von Segesser L, Gallino A. Telementoring during endovascular treatment of abdominal aortic aneurysms: a prospective study. J Endovasc Ther. 2005 Apr;12(2):200-5 (I. F. 2.838; Max. R. 0.754)
Wyttenbach R, Gallino A, Alerci M, Mahler F, Di Valentino M, Badimon JJ, Fuster V, Corti R. Effects of percutaneous transluminal angioplasty and endovascular brachytherapy on vascular remodeling of human femoropopliteal artery by noninvasive magnetic resonance imaging. Circulation. 2004 Aug 31;110(9):1156-61 (I. F. 19.309; Max. R. 1)